Cellebrite DI Ltd. (CLBT)
(Real Time Quote from BATS)
$12.52 USD
+0.12 (0.97%)
Updated Aug 6, 2024 10:02 AM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Income Statements
Fiscal Year end for Cellebrite DI Ltd falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 325 | 271 | 246 | 0 | 172 |
Cost Of Goods | 53 | 51 | 43 | 0 | 36 |
Gross Profit | 272 | 220 | 204 | 0 | 136 |
Selling & Adminstrative & Depr. & Amort Expenses | 239 | 219 | 190 | 0 | 138 |
Income After Depreciation & Amortization | 33 | 1 | 14 | 0 | -2 |
Non-Operating Income | -109 | 120 | 68 | 0 | 3 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -76 | 121 | 82 | 0 | 1 |
Income Taxes | 6 | 0 | 11 | 0 | 3 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -81 | 121 | 71 | 0 | -2 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -81 | 121 | 71 | 0 | -2 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 42 | 10 | 21 | 0 | 3 |
Depreciation & Amortization (Cash Flow) | 9 | 9 | 7 | 0 | 4 |
Income After Depreciation & Amortization | 33 | 1 | 14 | 0 | -2 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 190.16 | 195.39 | 161.54 | NA | NA |
Diluted EPS Before Non-Recurring Items | 0.18 | 0.03 | 0.20 | NA | NA |
Diluted Net EPS (GAAP) | -0.43 | 0.59 | 0.44 | -0.01 | NA |
Fiscal Year end for Cellebrite DI Ltd falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 89.58 | 93.01 | 84.18 | 76.68 |
Cost Of Goods | NA | 13.26 | 14.92 | 12.88 | 13.03 |
Gross Profit | NA | 76.32 | 78.10 | 71.30 | 63.65 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 67.07 | 63.10 | 57.82 | 59.03 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 9.25 | 15.00 | 13.48 | 4.62 |
Non-Operating Income | NA | -78.58 | -27.34 | -6.63 | -36.05 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -69.33 | -12.35 | 6.85 | -31.43 |
Income Taxes | NA | 2.04 | 2.30 | 0.35 | 0.92 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -71.37 | -14.65 | 6.50 | -32.35 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -71.37 | -14.65 | 6.50 | -32.35 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 196.82 | 194.44 | 204.39 | 199.71 |
Diluted EPS Before Non-Recurring Items | NA | 0.08 | 0.08 | 0.09 | 0.05 |
Diluted Net EPS (GAAP) | NA | -0.36 | -0.08 | 0.03 | -0.17 |